Atlas Trials

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

Clinical trial NCT02501850 · UNKNOWN

Trial details

NCT number
NCT02501850
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2014-10-01
Primary completion
2015-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.